Get started
Author

Maram Alotaibi

Observed names: Maram Al-Otaibi, MaramA Alotaibi
Observed institutions: Riyadh Armed Forces Hospital, King Saud Medical City, King Saud University, King Abdulaziz Medical City, Armed Forces Hospital, King Khalid University Hospital, National Guard Health Affairs
ORCID: 0000-0002-6383-2301
Observed ORCID: 0000-0002-6383-2301
OpenAlex ID: A5042969990
Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2017 · Je-Gun Joung, Bo Young Oh, et al. · Clinical Cancer Research · 109
Association of IL-13 rs20541 and rs1295686 variants with symptomatic asthma in a Saudi Arabian population
2017 · Rabih Halwani, Alejandro Vazquez-Tello, et al. · Journal of Asthma · 20
Residual Cough and Asthma-like Symptoms Post-COVID-19 in Children
2023 · Abdullah Al-Shamrani, Khalid Al-Shamrani, et al. · Children · 10
PDF
Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease
2020 · Reem Al-Qarni, Muhammad Iqbal, et al. · Medicine · 9
Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease
2020 · FaisalA Alsaif, SaraH Alqahtani, et al. · Saudi Journal of Gastroenterology · 8
Prescription Pattern of Empirical Antibiotic Therapy in the Burn Unit of a Tertiary Care Setting in the Kingdom of Saudi Arabia
2021 · Khaja Moinuddin, Deemah Sattam Alanazi, et al. · Journal of Pharmacy And Bioallied Sciences · 5
Pro106Leu MPL mutation is associated with thrombocytosis and a low risk of thrombosis, splenomegaly and marrow fibrosis
2022 · Musa Alzahrani, Saeed Al Turki, et al. · Platelets · 3
Sjogren–Larsson Syndrome: A case series of five members from an extended family with a novel mutation
2020 · Kamel T. Abidi, Naglaa M. Kamal, et al. · Molecular Genetics & Genomic Medicine · 3
PDF
Clinicopathological Description from the Largest Series of Patients with the Novel Pro106Leu MPL gene Mutation Associated with Hereditary Thrombocythemia
2020 · Musa Alzahrani, Areej Al Mugairi, et al. · Blood · 1
Table S2 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Figure S1 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Figure S3 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Table S1 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Supplementary Figure Legends from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Figure S1 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Table S2 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Table S1 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Figure S2 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Data from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
Figure S2 from Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
2023 · Je-Gun Joung, Bo Young Oh, et al.
The Role of Nuclear Receptor Coactivator Aib1/src3 in Normal and Breast Cancer Stromal Functions
2012 · Maram Alotaibi · ProQuest Demo Repository
Works count: 21
Citation count: 168
H-index: 5
I10-index: 3
Year
Topic
Type